Prevalence of endometriosis in epithelial ovarian cancer. Analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality

European Journal of Gynaecological Oncology

Volumn 36, Issue 1, 2015, Pages 21-24

  Machado Linde, F ^a   Sanchez Ferrer M L ^a   Cascales, P ^a   Torroba, A ^a   Orozco, R ^a   Silva Sanchez Y ^a   Nieto, A ^a   Fiol, G ^b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL TORRECÁRDENAS   (Spain)

Author keywords

Endometriosis; Ovarian cancer

Indexed keywords

ADULT; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MIDDLE AGED; MOLECULAR BIOLOGY; OVARY CARCINOMA; PREVALENCE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; ADENOCARCINOMA, CLEAR CELL; AGED; CARCINOMA, ENDOMETRIOID; OVARIAN NEOPLASMS; PATHOLOGY; SPAIN;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; SPAIN;

EID: 84924690852     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/ejgo2548.2015     Document Type: Article

References (37)

1. Bulun S.E.: "Endometriosis". N. Engl. J. Med., 2009, 360, 268.
2. Jenkins S., Olive D.L., Haney A.F.: "Endometriosis: pathogenic implications of the anatomic distribution". Obstet. Gynecol., 1986, 67, 335.
3. Missmer S.A., Cramer D.W.: "The epidemiology of endometriosis". Obstet. Gynecol. Clin. North Am., 2003, 30, 1.
4. Sampson J.A.: "Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity". Am. J. Obstet. Gynecol., 1927, 14, 422.
5. Garry R.: "Endometriosis: an invasive disease". Gynecol. Endosc, 2001, 10, 79.
6. Rossing M.A., Cushing-Haugen K.L., Wicklund K.G., Doherty J.A., Weiss N.S.: "Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery". Cancer Causes Control, 2008, 19, 1357.
7. Brinton L.A., Gridley G., Persson I., Baron J., Bergqvist A.: "Cancer risk after a hospital discharge diagnosis of endometriosis". Am. J. Obstet. Gynecol., 1997, 176, 572.
8. Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B J., et al.: "Infertility, fertility drugs, and ovarian cancer a pooled analysis of case-control studies". Am. J. Epidemiol, 2002, 155, 217.
9. Wu A.H., Pearce C.L., Tseng C.C., Templeman C., Pike M.C.: "Markers of inflammation and risk of ovarian cancer in Los Angeles County". Int. J. Cancer, 2009, 124, 1409.
10. Melin A., Sparén P., Persson I., Bergqvist A.: "Endometriosis and the risk of cancer with special emphasis on ovarian cancer". Hum. Reprod., 2006, 21, 1237.
11. Borgfeldt C., Andolf E.: "Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis". Acta Obstet. Gynecol. Scand., 2004, 83, 395.
12. Brinton L.A., Sakoda L.C., Sherman M.E., Frederiksen K., Kjaer S.K., Graubard B.I., et al.: "Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors". Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2929.
13. Ness R.B.: "Endometriosis and ovarian cancer: thoughts on shared pathophysiology". Am. J. Obstet. Gynecol., 2003, 189, 280.
14. Olson J.E., Cerhan J.R., Janney C.A., Anderson K.E., Vachon C.M., Sellers T.A.: "Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study". Cancer, 2002, 94, 1612.
15. Scully R.E.: "Histological typing of ovarian tumors". 2nd ed. New York: Springer-Verlag, 1999.
16. Van Gorp T., Amant F., Neven P., Vergote I., Moerman P.: "Endometriosis and the development of malignant tumours of the pelvis. A review of literature". Best Pract. Res. Clin. Obstet. Gynecol., 2004, 18, 349.
17. FIGO Committee on Gynecologic Oncology: "Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia". Int. J. Gynaecol. Obstet., 2009, 105, 3.
18. Somigliana E., Vigano P., Parazzini F., Stoppelli S., Giambattista E., Vercellini P.: "Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence". Gynecol. Oncol., 2006, 101, 331.
19. Viganò P., Somigliana E., Parazzini F., Vercellini P.: "Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer". Fertil Steril, 2007, 88, 588.
20. Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M. et al.: "Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies". Lancet Oncol., 2012, 13, 385.
21. Munksgaard P.S., Blaakaer J.: "The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations". Gynecol. Oncol., 2012, 124, 164.
22. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., Senz J., et al.: "ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363: 1532-43.
23. Samartzis E.P., Samartzis N., Noske A., Fedier A., Caduff R., Dedes K.J., et al.: "Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?" Mod. Pathol, 2012, 25, 885.
24. Yamamoto S., Tsuda H., Takano M., Tamai S., Matsubara O.: "PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma". Vtrchows Arch., 2012, 460, 77.
25. Wiegand K.C., Lee A.F., Al-Agha O.M., Chow C., Kalloger S.E., Scott D.W., et al.: "Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas". J. Pathol, 2011, 224, 328.
26. Ayhan A., Mao T.L., Seckin T., Wu C.H., Guan B., Ogawa H., et al.: "Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma". Int. J. Gynecol. Cancer, 2012, 22, 1310.
27. Brinton L.A., Melton L.J. 3rd., Malkasian G.D. Jr., Bond A., Hoover R.: "Cancer risk after evaluation for infertility". Am. J. Epidemiol, 1989, 129, 712.
28. Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B.J., et al.: "Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies". Am. J. Epidemiol, 2002, 155, 217.
29. Nagle C.M., Olsen C.M., Webb P.M., Jordan S.J., Whiteman D.C., Green A.C., et al.: "Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors". Eur. J. Cancer, 2008, 44, 2477.
30. de Ziegler D., Borghese B., Chapron C: "Endometriosis and infertility: pathophysiology and management". Lancet, 2010, 376, 730.
31. Merritt M.A., De Pari M., Vitonis A.F., Titus L.J., Cramer D.W., Terry K.L.: "Reproductive characteristics in relation to ovarian cancer risk by histologic pathways". Hum. Reprod., 2013, 28, 1406. doi:10.1093/humrep/des466. Epub 2013 Jan 12.
32. Cuff J., Longacre T. A.: "Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type". Am. J. Surg. Pathol, 2012, 36, 688.
33. Orezzoli J.P., Russell A.H., Oliva E., Del Carmen M.G., Eichhorn J., Fuller A.F.: "Prognostic implication of endometriosis in clear cell carcinoma of the ovary". Gynecol. Oncol., 2008, 110, 336.
34. Chan J.K., Teoh D., Hu J.M., Shin J.Y., Osann K., Kapp D.S.: "Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers". Gynecol. Oncol., 2008, 109, 370.
35. Kumar S., Munkarah A., Arabi H., Bandyopadhyay S., Semaan A., Hayek K., et al.: "Prognostic analysis of ovarian cancer associated with endometriosis". Am. J. Obstet. Gynecol., 2011, 204, 63.el.
36. Melin A., Lundholm C., Malki N., Swahn M.L., Sparen P., Bergqvist A.: "Endometriosis as a prognostic factor for cancer survival". Int. J. Cancer, 2011, 129, 948.
37. Katagiri A., Nakayama K., Rahman M.T., Katagiri H., Nakayama N., Ishikawa M., et al: "Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma". Mod. Pathol, 2012, 25, 282.